iTransform: Wearable Biosensors to Detect the Evolution of Opioid Tolerance in Opioid Naïve Individuals

iTransform:可穿戴生物传感器检测阿片类药物耐受性的演变

基本信息

项目摘要

PROJECT SUMMARY The integrated research and training plans outlined in this K23 submission will prepare me for a career as a clinician-scientist conducting translational substance abuse research. My career goal is to perform hypothesis- driven original research investigations directed toward reducing morbidity and mortality from opioid overdose. In this proposal, I intend to deploy wearable biosensors (small devices that continuously record physiology) to study the effects of therapeutic administration of opioid analgesics. I have already studied wearable biosensors in individuals receiving opioids; my preliminary data demonstrates that opioid-tolerant individuals have different biometric signals than non-tolerant individuals. This observation suggests that biosensors can be used to identify the onset of tolerance, an important event that correlates with higher doses of opioid analgesics, and higher risk of death from opioid overdose. Biosensor data management and analysis requires signal processing, data analytic, and machine learning techniques; these approaches are beyond the areas of traditional medical training. My short-term goal is to utilize this K23 award to fill my knowledge gaps in wearable biosensing and advanced data analysis so that I can generate ever more innovative responses to the problem of opioid prescribing, tolerance, misuse, addiction, and overdose. To optimize this important line of investigation, I have developed a training plan that includes: 1) completing a PhD through the Millennium PhD program; 2) expanding my skills in wearable biosensing and behavioral health-based research; 3) developing an understanding of signal processing and machine learning; 4) developing data analytic and data science skills; and 5) expanding my research presentation and dissemination skills. I will achieve these goals through directed coursework, focused seminars, and practical experience. My mentorship team of expert investigators who will ensure my productivity and success includes E. Boyer (primary mentor), D. Smelson, J. Fang, and P. Indic (secondary mentors), and D. Ganesan (advisor) My research plan has three specific aims: 1) to deploy a wearable biosensor technology to detect digital biomarkers associated with the initiation of opioid analgesic therapy in an opioid naïve population; 2) to use signal-processing analytics to identify transitions in digital biomarkers with progressive opioid use and to identify individual characteristics associated with this transition; and, 3) to apply and explore supervised learning algorithms that can predict transitions in digital biomarkers that herald the onset of opioid tolerance. To identify dynamic patterns in response to opioids, I will study the digital biomarkers of opioid-naïve patients with acute fractures who are prescribed opioid analgesics. Results will be used to develop “big data” approaches to apply predictive algorithms to identify the onset of opioid tolerance. This work has the potential to prevent development of problematic opioid use and will provide the basis for subsequent R01 submissions to implement sensor-based interventions triggered by the onset of tolerance in individuals receiving opioid analgesics.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STEPHANIE P CARREIRO其他文献

STEPHANIE P CARREIRO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STEPHANIE P CARREIRO', 18)}}的其他基金

RAE cHealth: A digital community support tool to promote recovery from substance use disorder
RAE cHealth:促进药物滥用障碍康复的数字社区支持工具
  • 批准号:
    10838804
  • 财政年份:
    2023
  • 资助金额:
    $ 18.86万
  • 项目类别:
The ANTIDOTE Institute- Advancing New Toxicology Investigators in Drug abuse and Original Translational research Efforts
ANTIDOTE Institute - 推动新毒理学研究人员在药物滥用和原创转化研究工作中的发展
  • 批准号:
    10681927
  • 财政年份:
    2023
  • 资助金额:
    $ 18.86万
  • 项目类别:
MINDER: Wearable sensor-based detection of digital biomarkers of adherence to medications for opioid use disorder
MINDER:基于可穿戴传感器的数字生物标记检测,用于检测阿片类药物使用障碍药物的依从性
  • 批准号:
    10656796
  • 财政年份:
    2023
  • 资助金额:
    $ 18.86万
  • 项目类别:
RAE cHealth: A digital community support tool to promote recovery from substance use disorder
RAE cHealth:促进药物滥用障碍康复的数字社区支持工具
  • 批准号:
    10469897
  • 财政年份:
    2022
  • 资助金额:
    $ 18.86万
  • 项目类别:
RAE (Realize, Analyze, Engage)- A Digital Biomarker Based Detection and Intervention System for Stress and Craving During Recovery from Substance Abuse Disorders
RAE(实现、分析、参与)——一种基于数字生物标记的检测和干预系统,用于治疗药物滥用疾病恢复过程中的压力和渴望
  • 批准号:
    10356481
  • 财政年份:
    2019
  • 资助金额:
    $ 18.86万
  • 项目类别:
RAE (Realize, Analyze, Engage)- A Digital Biomarker Based Detection and Intervention System for Stress and Craving During Recovery from Substance Abuse Disorders
RAE(实现、分析、参与)——一种基于数字生物标记的检测和干预系统,用于治疗药物滥用疾病恢复过程中的压力和渴望
  • 批准号:
    10370419
  • 财政年份:
    2019
  • 资助金额:
    $ 18.86万
  • 项目类别:
RAE (Realize, Analyze, Engage)- A Digital Biomarker Based Detection and Intervention System for Stress and Craving During Recovery from Substance Abuse Disorders
RAE(实现、分析、参与)——一种基于数字生物标记的检测和干预系统,用于治疗药物滥用疾病恢复过程中的压力和渴望
  • 批准号:
    9545385
  • 财政年份:
    2019
  • 资助金额:
    $ 18.86万
  • 项目类别:
RAE Health I-Corps
RAE Health I-Corps
  • 批准号:
    10045689
  • 财政年份:
    2019
  • 资助金额:
    $ 18.86万
  • 项目类别:

相似海外基金

Understanding age at first autism health claim and acute health service use in girls and women relative to boys and men
了解女孩和女性相对于男孩和男性的首次自闭症健康声明和紧急医疗服务使用情况
  • 批准号:
    419977
  • 财政年份:
    2020
  • 资助金额:
    $ 18.86万
  • 项目类别:
    Operating Grants
Study of pathogenic mechanism of age-dependent chromosome translocation in adult acute lymphoblastic leukemia
成人急性淋巴细胞白血病年龄依赖性染色体易位发病机制研究
  • 批准号:
    18K16103
  • 财政年份:
    2018
  • 资助金额:
    $ 18.86万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Proposal of a model plan for a high-activity operating department in an acute care hospital based on long-term PDCA in the age of minimally invasive treatment
微创治疗时代基于长期PDCA的急症医院高活动手术科室模型方案提出
  • 批准号:
    18K04486
  • 财政年份:
    2018
  • 资助金额:
    $ 18.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ISCHAEMIC ACUTE RENAL FAILURE AND AGE: MODULATION BY ANTI-INFLAMMATORY EMBRYONIC STEM CELL-DERIVED MACROPHAGES
缺血性急性肾衰竭和年龄:抗炎胚胎干细胞源性巨噬细胞的调节
  • 批准号:
    G0801235/1
  • 财政年份:
    2009
  • 资助金额:
    $ 18.86万
  • 项目类别:
    Research Grant
AGE-RELATED DIFFERENCES IN ENERGY EXPENDITURE IN RESPONSE TO ACUTE EXERCISE
剧烈运动时的能量消耗与年龄相关的差异
  • 批准号:
    7951393
  • 财政年份:
    2009
  • 资助金额:
    $ 18.86万
  • 项目类别:
Age factors, mutations, and chemical suppressors of acute myelogenous leukemia
急性髓性白血病的年龄因素、突变和化学抑制剂
  • 批准号:
    8306217
  • 财政年份:
    2008
  • 资助金额:
    $ 18.86万
  • 项目类别:
Age-related differences in the acute thermoregulatory responses to cold
对寒冷的急性体温调节反应与年龄相关的差异
  • 批准号:
    347633-2008
  • 财政年份:
    2008
  • 资助金额:
    $ 18.86万
  • 项目类别:
    Postgraduate Scholarships - Master's
Acute and chronic GPCR Medicated Cardioprotection: Roles of receptor Cross-Talk, Cellular signaling, and effects of Age
急性和慢性 GPCR 药物心脏保护:受体串扰的作用、细胞信号传导以及年龄的影响
  • 批准号:
    nhmrc : 428251
  • 财政年份:
    2008
  • 资助金额:
    $ 18.86万
  • 项目类别:
    Career Development Fellowships
Age factors, mutations, and chemical suppressors of acute myelogenous leukemia
急性髓性白血病的年龄因素、突变和化学抑制剂
  • 批准号:
    7530462
  • 财政年份:
    2008
  • 资助金额:
    $ 18.86万
  • 项目类别:
Age factors, mutations, and chemical suppressors of acute myelogenous leukemia
急性髓性白血病的年龄因素、突变和化学抑制剂
  • 批准号:
    8134266
  • 财政年份:
    2008
  • 资助金额:
    $ 18.86万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了